Acadia Healthcare (NASDAQ:ACHC) Upgraded by Deutsche Bank Aktiengesellschaft to Buy Rating

Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a buy rating in a research report released on Thursday, MarketBeat.com reports. The brokerage currently has $75.00 price objective on the stock, up from their previous price objective of $45.00.

A number of other analysts also recently weighed in on ACHC. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. KeyCorp initiated coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday. Finally, Royal Bank of Canada lowered their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $75.44.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $40.34 on Thursday. The stock has a market capitalization of $3.75 billion, a PE ratio of 13.23, a P/E/G ratio of 1.82 and a beta of 1.29. Acadia Healthcare has a 1 year low of $36.50 and a 1 year high of $87.77. The company’s 50 day simple moving average is $45.69 and its two-hundred day simple moving average is $61.98. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the firm posted $0.91 earnings per share. Analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Point72 Asset Management L.P. increased its stake in shares of Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after purchasing an additional 1,650,040 shares in the last quarter. Wellington Management Group LLP boosted its stake in Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares in the last quarter. Millennium Management LLC grew its position in Acadia Healthcare by 3,067.8% during the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after purchasing an additional 1,055,894 shares during the last quarter. Holocene Advisors LP raised its holdings in Acadia Healthcare by 201.5% in the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock worth $61,667,000 after buying an additional 649,997 shares during the last quarter. Finally, William Blair Investment Management LLC increased its position in shares of Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after acquiring an additional 604,070 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.